These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 19451471)

  • 1. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
    Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA
    Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of RAD17 in head and neck cancer.
    Zhao M; Begum S; Ha PK; Westra W; Califano J
    Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
    Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
    Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma.
    Slebos RJ; Yi Y; Ely K; Carter J; Evjen A; Zhang X; Shyr Y; Murphy BM; Cmelak AJ; Burkey BB; Netterville JL; Levy S; Yarbrough WG; Chung CH
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):701-9. PubMed ID: 16467079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of molecular targets in head and neck squamous cell carcinomas based on genome-wide gene expression profiling.
    Shimizu S; Seki N; Sugimoto T; Horiguchi S; Tanzawa H; Hanazawa T; Okamoto Y
    Oncol Rep; 2007 Dec; 18(6):1489-97. PubMed ID: 17982635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
    Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of P15 (MTS2) in head and neck squamous cell carcinomas.
    Roesler JM; Livingston EH; Srivatsan E; Chang P; Wang MB
    J Surg Res; 1998 Jun; 77(1):50-4. PubMed ID: 9698532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the expression of genes between normal tissue and squamous cell carcinomas of head and neck using cancer-related gene cDNA microarray.
    Kainuma K; Katsuno S; Hashimoto S; Oguchi T; Suzuki N; Asamura K; Usami S
    Acta Otolaryngol; 2006 Sep; 126(9):967-74. PubMed ID: 16864496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
    Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
    Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis.
    Squire JA; Bayani J; Luk C; Unwin L; Tokunaga J; MacMillan C; Irish J; Brown D; Gullane P; Kamel-Reid S
    Head Neck; 2002 Sep; 24(9):874-87. PubMed ID: 12211052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
    Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
    Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
    Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
    Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
    Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
    Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes.
    Freier K; Hofele C; Knoepfle K; Gross M; Devens F; Dyckhoff G; Plinkert P; Lichter P; Herold-Mende C
    J Oral Pathol Med; 2010 May; 39(5):382-9. PubMed ID: 20149059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of gene expression in head and neck carcinoma using laser capture microdissection and real-time reverse transcription polymerase chain reaction.
    Malhotra PS; Malekfzali A; Bonner RF; Juhn S; Van Waes C; Chen Z
    Laryngoscope; 2004 Dec; 114(12):2123-8. PubMed ID: 15564832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiles in HPV-infected head and neck cancer.
    Schlecht NF; Burk RD; Adrien L; Dunne A; Kawachi N; Sarta C; Chen Q; Brandwein-Gensler M; Prystowsky MB; Childs G; Smith RV; Belbin TJ
    J Pathol; 2007 Nov; 213(3):283-93. PubMed ID: 17893858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.